New McKinney biotech firm aims to integrate, simplify PCR testing
A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 test. Three Texas health care and biotechnology companies — McKinney-based Community Direct DX and Tyler-based Scienetix and Advanta Genetics R&D …